Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer

Retrieved on: 2021-08-17 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Remix Therapeutics Names Peter Smith, PhD, as President and Chief Executive Officer. View article details on hiswai:

Excerpt

17, 2021 /PRNewswire/ -- Remix Therapeutics, a biotechnology company developing small molecule therapies designed to reprogram RNA ...

Article found on: finance.yahoo.com